Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Datasea Reports First Quarter Fiscal Year 2024 Financial Results and Operations Update 2023-11-13 21:30
AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests 2023-11-13 21:00
PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE 2023-11-13 21:00
So-Young's Subsidiary Wuhan Miracle Submits Application Documents for Initial Public Offering on China's Beijing Stock Exchange 2023-11-13 19:30
BizLink once again proves its ability to innovate in healthcare robotics 2023-11-13 17:53
Nona Biosciences Announces Strategic Collaboration with GeneQuantum Healthcare to Empower Early Discovery of Next-Generation Bioconjugates 2023-11-13 16:04
111 to Announce Third Quarter 2023 Unaudited Financial Results on November 30, 2023 - Conference Call to Follow 2023-11-13 13:10
One-Stop Dental 3D Printing Solutions Provider to Showcase at the GNYDM 2023-11-13 10:53
PillWork Strengthens Global Ties Ahead of 2023 Launch with Strategic Partnerships 2023-11-13 08:00
Fapon Inaugurates State-of-the-Art R&D Center in Lexington, MA 2023-11-11 20:36
SeekIn Presents Retrospective and Prospective Validation Studies of SeekInCare Multi-omics Multi-cancer Early Detection test at the 20th ICGC Workshop and 7th ARGO Meeting in New York 2023-11-10 21:00
Lecheng, MSD vow to deepen medical cooperation 2023-11-10 18:03
So-Young to Report Third Quarter 2023 Financial Results on November 20, 2023 2023-11-10 18:00
FEBICO actively seeking business partners in United States, introduces "High- Spermidine" chlorella health supplements to satisfy U.S. market 2023-11-10 17:08
TCT 2023: The Efficacy and Safety of the SMART Trial Presented by World Renowned Expert 2023-11-10 16:46
GC Genome Enters License Agreement with MP Group 2023-11-10 13:00
MVR-T3011 IV, Global First Intravenous Oncolytic Product, Successfully Concludes Phase I Clinical Study in the U.S. with Outstanding Safety Results 2023-11-10 08:00
Beyond2020 Improves Access to Clean Water for 10,000 Rural Malaysians 2023-11-10 03:27
PharmAbcine Receives Safety Review Committee Approval to Advance to Dose Level 2 of Clinical Trial of PMC-403 with Neovascular Age-related Macular Degeneration following Dose Level 1 Safety Data 2023-11-09 21:00
WuXi AppTec Named 2023 Global Contract Research, Development and Manufacturing Organization Company of the Year by Frost & Sullivan 2023-11-09 08:00
1 26 27 28 29 30 762